T1	Genomic_variation	10 29	Genomic alterations
T2	Gene_or_protein	94 119	HER2 immunohistochemistry
T3	Disease	186 210	breast cancers that were
T4	Chemical	224 253	neoadjuvant chemotherapy with
T5	Chemical	254 303	paclitaxel , cyclophosphamid , epirubicin , fluor
T6	Chemical	303 322	ouracil , and trast
T7	Chemical	329 330	.
R1	isAssociatedWith	Arg1:T1	Arg2:T2
R2	isAssociatedWith	Arg1:T1	Arg2:T3
R3	isAssociatedWith	Arg1:T1	Arg2:T4
R4	isAssociatedWith	Arg1:T1	Arg2:T5
R5	isAssociatedWith	Arg1:T1	Arg2:T6
R6	isAssociatedWith	Arg1:T1	Arg2:T7
R7	isAssociatedWith	Arg1:T2	Arg2:T1
R8	isAssociatedWith	Arg1:T2	Arg2:T3
R9	isAssociatedWith	Arg1:T2	Arg2:T4
R10	isAssociatedWith	Arg1:T2	Arg2:T5
R11	isAssociatedWith	Arg1:T2	Arg2:T6
R12	isAssociatedWith	Arg1:T2	Arg2:T7
R13	isAssociatedWith	Arg1:T3	Arg2:T1
R14	isAssociatedWith	Arg1:T3	Arg2:T2
R15	isAssociatedWith	Arg1:T3	Arg2:T7
R16	treats	Arg1:T4	Arg2:T1
R17	treats	Arg1:T4	Arg2:T2
R18	treats	Arg1:T4	Arg2:T3
R19	treats	Arg1:T4	Arg2:T5
R20	treats	Arg1:T4	Arg2:T6
R21	treats	Arg1:T4	Arg2:T7
R22	treats	Arg1:T5	Arg2:T1
R23	treats	Arg1:T5	Arg2:T2
R24	treats	Arg1:T5	Arg2:T3
R25	influences	Arg1:T5	Arg2:T4
R26	influences	Arg1:T5	Arg2:T6
R27	treats	Arg1:T5	Arg2:T7
R28	treats	Arg1:T6	Arg2:T1
R29	treats	Arg1:T6	Arg2:T2
R30	treats	Arg1:T6	Arg2:T3
R31	influences	Arg1:T6	Arg2:T4
R32	influences	Arg1:T6	Arg2:T5
R33	treats	Arg1:T6	Arg2:T7
R34	isAssociatedWith	Arg1:T7	Arg2:T1
R35	isAssociatedWith	Arg1:T7	Arg2:T2
R36	isAssociatedWith	Arg1:T7	Arg2:T3
R37	influences	Arg1:T7	Arg2:T4
R38	influences	Arg1:T7	Arg2:T5
R39	influences	Arg1:T7	Arg2:T6
